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Background: Patients with pulmonary arterial hypertension often present with a mild obstruc-
tive lung pattern, however, the functional consequences are not known.
Methods: We analysed flow volume loops during exercise in 61 patients with precapillary pulmo-
nary hypertension (PH) (age 55  14 years) in comparison with 21 patients with COPD (60  12
years), 39 patients with pulmonary fibrosis (58  11 years) and 38 healthy controls (HC) (39  15
years). Inspiratory capacity (IC) was measured at rest, and during maximum exercise (max).
Results: HCexhibited a stable IC of 3.0 0.9 l at rest, and atmax. A reduction in IC of 2.6 0.8 l at
rest to 2.0 0.7 l at max was observed in patients with COPD. Patients with PH exhibited a signif-
icant reduction in IC from 2.3 0.6 l at rest to 2.1 0.6 l at max, while patients with pulmonary
fibrosis exhibited a stable IC of 1.8 0.6 at rest and 1.7 0.6 l at max. In patients with PH, a weak
negative correlationwas drawn between the change in IC (%) and peak VO2 (rZ0.29, pZ 0.01),
as well as with PVR (rZ 0.27, pZ 0.02).
Conclusion: Patients with PH demonstrate a characteristic change in IC during exercise, which
might contribute to impaired exercise tolerance.
ª 2011 Elsevier Ltd. All rights reserved.Introduction
Precapillary pulmonary hypertension (PH) is a disease char-
acterised by progressive pulmonary vascular and rightof Giessen Lung Center, Univer
41 985 42599.
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1 Elsevier Ltd. All rights reservedventricular dysfunction, leading to impaired exercise toler-
ance.1 Additionally, patients with PH without preexisting
obstructive or interstitial lung disease exhibit a change in
airway function and breathing mechanics. A mild obstructivesity Hospital Giessen, Klinikstrasse 33, 35392 Giessen, Germany.
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Dynamic hyperinflation in pulmonary hypertension 309pattern in pulmonary function tests has been described in
patients with pulmonary arterial hypertension (PAH), as well
as chronic thromboembolic pulmonary hypertension
(CTEPH).2e4 Although the expiratory airflow limitation might
be minor at rest, it could lead to more pronounced changes
during exercise with limiting exercise tolerance.
The causes of impaired airway function in PH are not
known. Possible explanations include the mechanical
impairment of peripheral airway function by the dilated
precapillary pulmonary artery vessels or an effect of
pulmonary vascular remodelling involving the adventitia
with subsequent impairment of the adjacent airways.2,5
The consequences of airway obstruction on exercise
capacity are best described in patients with chronic
obstructive pulmonary disease (COPD) with a characteristic
shift of lung volumes during exercise due to air trapping and
subsequent impaired expansion of tidal volume. The
decrease in inspiratory capacity (IC) accompanied by an
increase inend-expiratory lung volume (EELV) during exercise
is the typical finding of dynamic hyperinflation (DH).6 A
change in the IC during exercise has also been described in
pulmonary fibrosis and in congestive heart failure.7,8 If
a change of IC during exercise occurs also in PH is not known.
Measurement of IC can be reliably performed by recording
flowevolumeeloops at rest and maximum exercise during
routine cardiopulmonary exercise test (CPET).9 The ratio of
tidal volume (VT)/IC and IC/total lung capacity TLC,
respectively, is regarded as a sensitive measure of utilisation
of ventilatory reserves during exercise.5
In the present study, we analyse whether patient with
PH exhibit a characteristic pattern of IC during exercise in
comparison to patients with COPD and pulmonary fibrosis,
as well as healthy controls (HC).Methods
In this single-centre study at the University of Giessen Lung
Center, we included patients with established COPD,
pulmonary fibrosis, and pulmonary hypertension (either
PAH or CTEPH). Patients were referred for further assess-
ment of disease severity and underwent routine CPET when
clinically stable. Furthermore, we included healthy indi-
viduals who underwent CPET to assess their individual
exercise capacity (HC). The study was performed between
March 2007 and March 2008.
After taking the patient’s history and performing
a physical examination, all patients underwent a pulmonary
function test including Diffusion capacity for Carbon
monoxide (DLCO), blood gas analysis from an arterialised
earlobe sample, and a 12-lead electrocardiogram (ECG) at
rest. Patients underwent cardiopulmonary exercise test
(Vmax 229 Sensormedics, Care Fusion, Yorba Linda, CA,
USA). Patients were asked to exercise up to their individual
limit on an exercise bicycle in a semi-supine position. The
exercise protocol included an increase in exercise load of
30 W every 2 min. The heart rate, ECG and oxygen satu-
ration were recorded continuously, and blood pressure was
measured every 2 min. Blood gas analyses from arterialised
earlobe samples were retrieved at rest and at maximum
exercise to calculate alveolarearterial oxygen difference
(AaDO2). In patients with PH, right to left shunting had beenexcluded prior by standardized contrast enhanced trans-
cranial Doppler sonography.10
The DH was evaluated by measuring IC at the end of
a normal expiration at the level of the end-expiratory lung
volume at rest, and during maximum exercise (max).9,11 A
breathing manoeuvre was started after registration of three
regular and uniform breathing cycles. At the end of expi-
ration patients were instructed to take a deep and
maximum inspiration followed by a deep expiration. This
instruction was repeated prior to and during every IC
measurement. The IC was calculated using the recorded
flow volume loop. Measurement of IC at rest was performed
twice with a maximum variability of 10%. The mean value of
both measurements was used in the study. The CPET and
measurement of IC was performed 1e2 days before any
invasive procedure. In patients with PH, a further workup e
according to current guidelines e including right heart
catheter, measurement of brain natriuretic peptide (BNP)
and 6 min walking distance (6MWD) was performed. Diag-
nosis of precapillary PH was confirmed by right heart
catheter investigation, defined by a mean pulmonary artery
pressure (mPAP) > 25 mmHg, a pulmonary arterial occlu-
sion pressure (PAOP) < 15 mm Hg and a normal or reduced
cardiac index (CI). Furthermore, patients with manifest PH
underwent radiological investigations, including thoracic
computed tomography (CT), a CT pulmonary angiogram,
and a perfusion scintigraphy scan to detect chronic
thromboembolism as an underlying cause of PH.1
Patients with COPD were diagnosed according to history,
symptoms and lung function test in concordance with
current guidelines.12 Patients with interstitial lung disease
were diagnosed according to history, pulmonary function
tests, high resolution CT scan, and bronchoscopy, if indi-
cated. The final diagnosis was made in a multidisciplinary
pathologicaleradiologicaleclinical panel.13 Patients with
COPD and pulmonary fibrosis did not exhibit signs of
pulmonary hypertension on transthoracic echocardiog-
raphy, ECG or imaging studies. HC presented with an
uneventful medical history and physical examination and
a normal lung function test at rest.
Statistical analysis: All data were tested for normal
distribution by means of KolmogoroveSmirnov testing.
Parameters with normal distributions were displayed as
mean  SD. To test for significant differences between
groups, the two-tailed Student’s t-test was used. Statistical
significant changes of IC from rest to exercise have been
tested with a paired t-test. In cases of multiple testing,
correction according to Bonferroni was applied to avoid
a type I error. Correlations between two variables were
analysed using the Pearson correlation coefficient. A p-
value < 0.05 was considered as statistically significant.14
Patients gave written informed consent for entering the
study. The study has been approved by the Ethics
Committee of the Medical Division of the Justus Liebig
University of Giessen (approval number 112/11).Results
We included 121 patients and 38 healthy controls, among
them 75 women with a mean age of 5315 years. There were
21 patients with COPD, in GOLD stage I (n Z 3), stage II
310 M.J. Richter et al.(n Z 12), stage III (n Z 5) and stage IV (n Z 1). In the
fibrosis group, there were 39 patients with a restrictive lung
function pattern due to idiopathic pulmonary fibrosis
(n Z 30), cryptogenic organising pneumonia (n Z 2),
chronic hypersensitivity pneumonitis (n Z 6) and respira-
tory bronchiolitis- interstitial lung disease (n Z 1).
Among the 61 patients with PH there were 31 patients
with idiopathic PAH (nZ 22), PAH associated with collagen
vascular disease without interstitial lung disease (n Z 5),
PAH due to corrected congenital heart disease (nZ 3), PAH
associated with liver disorder (nZ 1), and 30 patients with
inoperable CTEPH. Patients were in WHO functional class I
(nZ 6), class II (nZ 25), class III (nZ 30). None of the PH
patients were current smokers, 19 PH patients had stopped
smoking >20 years ago with a load less than 10 pack years.
Haemodynamic assessment confirmed manifest pulmonary
hypertension with a mean pulmonary artery pressure
(mPAP) of 47  15 mmHg, cardiac index of 2.5  0.6 l/min/
qm, pulmonary capillary occlusion pressure (PAOP) of
8  3 mm Hg, and pulmonary vascular resistance (PVR) of
734  388 dyn*s*cm5. The 6MWD was 451  120 m. The
serum concentration of BNP was 119  128 pg/ml. Patients
received targeted treatment for pulmonary hypertension
with endothelin receptor blocker (n Z 14), inhaled pros-
tanoids (n Z 2), phosphodiesterase V inhibitors (n Z 40),
and calcium channel blockers (n Z 5). In the HC group we
included 38 healthy volunteers. Anthropometric and lung
function data are presented in Table 1.
Peak oxygen uptake (VO2 peak) was significantly reduced
in patient groups compared to HC. Furthermore, there were
altered breathing parameters during maximum exercise
with a reduced ventilation (VE max) and tidal volume (VT
max) in the patient groups compared to HC, according to
the underlying respiratory disease, as illustrated in Table 2.
Patients stopped exercise due to dyspnoea (54%),
peripheral leg fatigue (34%), or other reasons, e.g.Table 1 Baseline characteristics and pulmonary function
tests values represent mean  SD; for abbreviations, see
text.
COPD
(n Z 21)
Fibrosis
(n Z 3 9)
PH
(n Z 61)
HC
(n Z 38)
Male/female 15/6 22/17 26/35 21/17
Age 60  12b 58  11b 55  14a 39  15
Height (cm) 174  10 171  10 170  10 174  12
Weight (kg) 84  19 79  14 74  15 77  16
FEV1 (I) (% pred)
2.0  0.6 2.1  0.8 2.5  0.8 3.6  1.1
63  15b 73  20b 88  20a 100  13
VC (I) (% pred)
3.3  0.9 2.6  0.9 3.4  1.1 4.4  1.4
81  17b 69  18b 94  16 97  13
FEV1/VC (%) 61  8 82  5 73  7 83  6
TLC (I) (%pred)
6.8  1.2 4.7  1.3 6.2  1.5 6.9  2.0
105  18 76  15 106  14 108  15
DLCO (%pred) 61  20b 49  16b 64  14b 88  9
a p < 0.01.
b p < 0.001 versus HC.problems with the mouthpiece (12%), whereas HC stopped
exercise due to dyspnoea (18%), peripheral leg fatigue
(66%), or other reasons (16%).
In the HC group, no change in IC at rest and during
exercise was observed. Patients with COPD exhibited
a significant decrease in IC at maximum exercise, while IC
at rest was comparable to that of the HC group. In patients
with pulmonary fibrosis, the IC at rest was significantly
reduced compared to the HC group, but did not change
during maximum exercise. In patients with PH, the IC at
rest was significantly reduced compared to the HC group.
There was a significant reduction in IC during maximum
exercise compared to resting IC (Table 2).
The delta IC in the PH group was normally distributed
(Kolmogornov Smirnov Z 0,53).
A similar disease characteristic pattern was observed
when using the ratio of IC/TLC (Table 2, Fig. 1). The ratio of
VT/IC at rest and during exercise was significantly higher in
all patients compared to the HC group, but was highest in
fibrosis and PH (Table 2).
There was a significant increase in VT and VT/IC ratio in
all groups during exercise. In all patient groups, the pCO2
minimally increased during exercise compared to baseline.
The IC and the IC/TLC ratio did significantly decrease in
COPD and PH patients during exercise (Table 2).
In the PH patient group, there was a significant increase
in VT and VT/IC during exercise in all WHO-classes, whereas
IC and IC/TLC slightly decreased from rest to maximum
exercise (statistically significant in WHO class II and III).
(Table 4).
Because of an unequal gender distribution in the PH-
group we separately analysed the IC in male and female
patients separately. We found a significant higher IC at rest
and maximum exercise in male patients, which confirms
previous findings.15 However the reduction of IC at exercise
was similar in both gender groups as displayed by a similar
delta IC and IC/TLC ratio at rest and max, respectively.
Data are shown in Table 3.
Patients with PH exhibited significant differences in
haemodynamic parameters, 6MWD and BNP depending on
the WHO functional class. Furthermore VO2 peak, but also
IC at rest and at maximum exercise decreased significantly
with respect to clinical classification (Table 4 and Fig. 2).
There was a weak negative correlation between the change
in IC (%) and peak VO2 (rZ 0.29; pZ 0.01) as well as PVR
(r Z 0.27; p Z 0.02) but not with maximum Watt. There
were no significant changes between patients with PAH or
CTEPH in exercise parameters (data not shown).Discussion
Patients with respiratory diseases exhibited characteristic
changes in breathing mechanics during exercise. In the
present study we describe the pattern of IC, the IC related
to TLC and VT/IC ratio at rest and during exercise in
patients with precapillary PH in direct comparison with
obstructive and restrictive respiratory diseases, and
healthy controls, respectively.
In PH patients, resting IC was reduced similar to COPD
and fibrosis, but significantly lower compared to the HC
group. This might be a consequence of impaired respiratory
Table 2 Cardiopulmonary exercise test and inspiratory capacity: comparison between rest and exercise and between patient
groups and healthy controls values represent mean  SD; for abbreviations, see text.
Parameter COPD (n Z 21) Fibrosis (n Z 39) PH (n Z 61) HC (n Z 38)
Watt (max) 90  27a 101  35a 81  37a 166  79
Max Heart rate (/min) 120  16 127  19 131  22 149  23
% Heart Rate Reserve 75  9 78  10 80  11 83  11
VO2 peak (ml/kg/min) 13.4  4.7a 15.5  4.6a 13.7  3.9a 25.3  10.1
VE max (l/min) 47  16f 57  19 54  18c 66  29
% breathing reserve 71  18 83  29 65  19 52  16
VT rest (l) 0.8  0.2 0.7  0.1 0.9  0.3 0.8  0.3
VT max (l) 1.6  0.5b,d 1.6  0.5a,d 1.8  0.6c,d 2.1  0.7d
IC rest (l) 2.6  0.8 1.8  0.6a 2.3  0.6b 3.0  0.9
IC max (l) 2.0  0.7a,d 1.7  0.6a 2.1  0.6a,d 3.0  0.9
delta IC (%) 20  13a 2  12 7  13a 1  8
VT/IC rest (%) 35  8b 42  12a 40  10a 28  7
VT/IC max (%) 79  16c,d 90  13a,d 84  17a,d 70  12d
IC rest/TLC (%) 37  8b 38  7b 38  7b 44  8
IC max/TLC (%) 30  7b,d 37  7b 35  7b,d 44  8
pO2rest (mmHg) 70  7a 73  8a 69  12a 83  7
pO2 max (mmHg) 69  13a 60  15a,d 64  15a,e 88  11f
pCO2 rest (mmHg) 37  3 38  3 32  4a 38  3
pCO2 max (mmHg) 40  5a,e 40  4d 33  4a,f 38  4
a p < 0.001.
b p < 0.01.
c p < 0.05 versus HC.
d p < 0.001.
e p < 0.01.
f p < 0.05 versus rest.
- mean IC/TLC % ± SD at rest 
    - mean IC/TLC % ± SD at maximum exercise 
* p< 0.0001 between IC at rest and at maximum exercise. 
p< 0.001 between rest and maximum exercise. 
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Figure 1 Comparison of inspiratory capacity related to TLC
at rest and during maximum exercise in patients with COPD,
pulmonary fibrosis, PH, and HC.
Dynamic hyperinflation in pulmonary hypertension 311muscle function, a well know feature of COPD and pulmo-
nary fibrosis but also PH.16
During exercise PH patients showed a significant reduc-
tion of IC without maximum utilisation of breathing
reserves or overt respiratory muscular fatigue, as displayed
by a stable exercise pCO2. This effect can be related to
exercise induced dynamic hyperinflation in PH patients.
The degree of IC reduction was associated with the WHO
functional classification of PH, and with the functional
parameter VO2 peak, as well as with 6MWD (albeit weakly).
However, there was only a weak association with haemo-
dynamic parameters.
We deliberately included patient with distinct respira-
tory disease and HC in our study for direct comparison of IC
at rest and during exercise. So we were able to describe the
typical pattern of IC change according to the underlying
disorder in an identical clinical setting (Fig. 1). Patients
with PH, COPD, or fibrosis showed a similar reduced IC
compared to HC. COPD patients with COPD exhibited the
characteristic decrease in IC during exercise as a conse-
quence of dynamic hyperinflation.6,17,18 In patients with
pulmonary fibrosis the IC did not change during exercise
due to restrictive lung disease.8,11 In PH, there was
a significant decrease in IC during exercise but less
pronounced compared to COPD, whereas in HC, IC was
identical at rest and during exercise.
The VT/IC ratio as a measure of the utilisation of
ventilatory reserves was significantly changed in all patient
groups compared to the HC group, but did not exhibit
a characteristic pattern with regard to the underlying
disorder (Table 2).
Table 3 Inspiratory capacity at rest and maximum exer-
cise in patients with PH according to gender. Values
represent mean  SD; for abbreviations, see text.
Parameter male
(n Z 26)
female
(n Z 35)
IC rest (l) 2.8  0.6a 2.0  0.4
IC max (l) 2.6  0.5a 1.8  0.4
delta IC (%) 5.7  11 8.5  13
IC rest/TLC (%) 38  7 38  7
IC max/TLC (%) 35  6 34  7
a p < 0.001, male versus female.
312 M.J. Richter et al.Changes in ventilatory parameter during exercise might
be influenced by body position during exercise. The
potential impact on airway closure might influence
comparison with other studies using a different exerciseTable 4 Cardiopulmonary exercise test and inspiratory
capacity in patients with PH according to functional clas-
sification values represent mean  SD; for abbreviations,
see text.
Parameter WHO FC I
(n Z 6)
WHO FC II
(n Z 25)
WHO FC III
(n Z 30)
Watt (max) 133  46 80  24 72  37
Max. heart
rate (/min)
149  20 134  20 126  22
% Heart rate
reserve
85  11 81  10 78  12
VO2 peak
(ml/kg/min)
19.0  3.2 13.5  2.8 12.8  4.1
VE max (l/min) 66.6  24 54.0  14.4 52.3  19
% Breathing
reserve
57  19 68  24 65  14
VT rest (l) 1.0  0.5 0.8  0.2 0.9  0.2
VT max (l) 2.2  0.6d 1.7  0.6d 1.7  0.6d
IC rest (l) 3.2  0.5 2.2  0.4b 2.1  0.7a
IC max (l) 3.0  0.4 2.1  0.5a,e 2.0  0.7a,e
delta IC (%) 4  10 8  14b 8  13c
VT/IC rest (%) 36  6 37  8b 43  10a
VT/IC max (%) 78  17a,d 85  15b,d 85  18a,d
IC rest/TLC (%) 44  6 38  5b 36  8b
IC max/TLC (%) 42  6 34  5b,e 33  7b,e
pO2 rest (mmHg) 75  11 70  10 67  13
pO2 max (mmHg) 65  9 64  14 64  16
pCO2 rest (mmHg) 35  5 32  3 32  4
pCO2 max (mmHg) 38  6 33  4f 33  4
mPAP (mmHg) 45  16 47  17 46  14
PVR (dyn*s*cm
5
) 537  251 712  444 797  352
CI (l/min/qm) 2.7  0.7 2.6  0.7 2.2  0.6
6MWD (m) 565  94 479  93 404  124
BNP (pg/nl) 61  96 96  98 148  149
a p < 0.001.
b p < 0.01.
c p < 0.05 versus HC.
d p < 0.001.
e p < 0.01.
f p < 0.05 versus rest.protocol. However the differences between patients groups
within our study should be not affected, as all exercise
tests were performed in semi-supine position.
What does this observation add to our understanding of
exercise limitation in PH? Certainly, patients with PH are
mainly restricted due to cardiovascular impairment and
haemodynamic compromise with inappropriate increase in
cardiac output during exercise and subsequent changes in
muscle function, gas exchange and impaired breathing
efficacy.19 However, the degree of haemodynamic
compromise might not always explain the degree of
impaired exercise capacity in these patients. Furthermore,
exercise capacity measured by VO2 peak is significantly
higher during submaximal exercise compared to maximal
exercise tests in these patients.20
Patients with PH exhibit a mild obstructive lung pattern.
The expiratory airflow limitation might be minor or even
absent at rest, but could result in more pronounced
changes during exercise.2e4
The significant reduction of IC during exercise (similar to
DH in COPD) demonstrates the functional consequences of
ventilatory impairment in PH patients. These changes might
contribute to exercise intolerance in PH, however this is
only weakly supported by the negative correlation of
change in IC with VO2 peak and PVR. Based on these findings
we consider the role of DHI on exercise limitation in PH as
minor and limited to the early stages of the disease.
Patients with COPD benefit from pulmonary rehabilita-
tion with reduction of DH.21 It remains speculative whether
the beneficial effects of pulmonary rehabilitation in PHmight
also result in a reduction of DH pattern in these patients.22
The study has several limitations, particularly the
unequal distribution of patients in the disease groups, the- mean inspiratory capacity (IC) ± SD at rest 
    - mean IC ± SD at maximum exercise 
 *, ANOVA p<0.05 between groups. 
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Figure 2 Comparison of inspiratory capacity at rest and
during maximum exercise in patients with pulmonary hyper-
tension depending on functional classification.
Dynamic hyperinflation in pulmonary hypertension 313age difference in the HC group and the lack of assessment
of subjective exercise limitation according to Borg scale.
Furthermore, we did not relate these observations to
therapeutic interventions. This might be subject of further
investigations.
In conclusion, patients with PH exhibit a characteristic
reduction pattern of IC at rest and at maximum exercise
compared to patients with COPD, pulmonary fibrosis and
healthy controls. The reduction of IC during exercise might
be associated with reduced exercise capacity in PH.Conflict of interests
Manuel Jonas Richter: no conflict of interests related to
this study.
Robert Voswinckel: no conflict of interests related to
this study.
Henning Tiede: no conflict of interests related to this
study.
Richard Schulz: no conflict of interests related to this
study.
Christian Tanislav: no conflict of interests related to this
study.
Andreas Feustel: no conflict of interests related to this
study.
Rory E. Morty: no conflict of interests related to this
study.
Hossein Ardeschir Ghofrani: Conflict of interests: H.A.
Ghofrani receives grant and contract support by Pfizer Ltd.,
Altana Pharma AG, Schering AG; in addition, he serves on
advisory board of Pfizer Ltd.
Werner Seeger: Conflict of interests: W. Seeger receives
grant and contract support by Schering, Altana Pharma,
Myogen Inc. Westminster, LungRX and Aventis Pharma.
Frank Reichenberger: no conflict of interests related to
this study.Ethics statement
The study has been approved by the Ethics Committee of
the Medical Division of the, Justus Liebig University of
Giessen, Germany (approval number 112/11).Acknowledgements
The manuscript is part of the doctoral thesis of Manuel J
Richter.References
1. Task Force for Diagnosis and Treatment of Pulmonary Hyper-
tension of European Society of Cardiology (ESC), European
Respiratory Society (ERS), International Society of Heart and
Lung Transplantation (ISHLT), Galie` N, Hoeper MM, Humbert M,
et al. Guidelines for the diagnosis and treatment of pulmonary
hypertension. Eur Respir J 2009;34:1219e63.
2. Meyer FJ, Ewert R, Hoeper MM, et al. German PPH study group.
Peripheral airway obstruction in primary pulmonary hyper-
tension. Thorax 2002;57(6):473e6.3. Spiekerkoetter E, Fabel H, Hoeper MM. Effects of inhaled sal-
butamol in primary pulmonary hypertension. Eur Respir J 2002;
20(3):524e8.
4. SunXG,HansenJE,OudizRJ, etal.Pulmonary function inprimary
pulmonary hypertension. J Am Coll Cardiol 2003;41:1028e35.
5. Tudor RM, Zaiman AL. Pathology of pulmonary vascular
disease. In: Peacock AJ, Rubin LJ, editors. Pulmonary circu-
lation. diseases and their treatment. Part 2: pathophysiology
and pathology of pulmonary vascular disease. London: Arnold
Publisher; 2004. p. 25e32.
6. O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and
exercise intolerance in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med 2001;164(5):770e7.
7. Papazachou O, Anastasiou-Nana M, Sakellariou D, et al.
Pulmonary function at peak exercise in patients with chronic
heart failure. Int J Cardiol 2007;118(1):28e35.
8. O’Donnell DE, Chau LK, Webb KA. Qualitative aspects of
exertional dyspnea in patients with interstitial lung disease.
J Appl Physiol 1998;84(6):2000e9.
9. Johnson BD, Weisman IM, Zeballos RJ, et al. Emerging concepts
in the evaluation of ventilatory limitation during exercise: the
exercise tidal flow-volume loop. Chest 1999;116(2):488e503.
10. Jauss M, Zanette E. Detection of right-to-left shunt with
ultrasound contrast agent and transcranial Doppler sonog-
raphy. Cerebrovasc Dis 2000;10:490e6.
11. O’Donnell DE, Ofir D, Laveneziana P. Patterns of cardiopul-
monary response to exercise in lung diseases. Eur Respir Mon
2007;40:69e92.
12. Celli BR, MacNee W. ATS/ERS task force. Standards for the
diagnosis and treatment of patients with COPD: a summary of
the ATS/ERS position paper. Eur Respir J 2004;23(6):932e46.
13. Bradley B, Branley HM, Egan JJ, , et alBritish Thoracic Society
Interstitial Lung Disease Guideline Group, British Thoracic
Society Standards of Care Committee, Thoracic Society of
Australia, New Zealand Thoracic Society, Irish Thoracic
Society. Interstitial lung disease guideline: the British Thoracic
Society in collaboration with the Thoracic Society of Australia
and New Zealand and the Irish Thoracic Society. Thorax 2008;
3(Suppl. 5):1e58.
14. Goodman T. Towards evidence e based medical statistics. Ann
Intern Med 1999;130:995e1013.
15. Tantucci C, Pinelli V, Cossi S, Guerini M, Donato F, Grassi V.
Reference values and repeatability of inspiratory capacity for
men and women aged 65e85. Respir Med 2006;100(5):871e7.
16. Kabitz HJ, Schwoerer A, Bremer HC, et al. Impairment of
respiratory muscle function in pulmonary hypertension. Clin
Sci (Lond) 2008;114(2):165e71.
17. Ofir D, Laveneziana P, Webb KA, et al. Mechanisms of dyspnea
during cycle exercise in symptomatic patients with GOLD stage
I chronic obstructive pulmonary disease. Am J Respir Crit Care
Med 2008;177(6):622e9.
18. O’Donnell DE, Webb KA. Exertional breathlessness in patients
with chronic airflow limitation. The role of lung hyperinflation.
Am Rev Respir Dis 1993;148(5):1351e7.
19. Sun XG, Hansen JE, Oudiz RJ, et al. Exercise pathophysiology in
patients with primary pulmonary hypertension. Circulation
2001;104:429e35.
20. Deboeck G, Niset G, Vachiery JL, et al. Physiological response
to the six-minute walk test in pulmonary arterial hypertension.
Eur Respir J 2005;26:667e72.
21. Porszasz J, Emtner M, Goto S, et al. Exercise training decreases
ventilatory requirements and exercise-induced hyperinflation
at submaximal intensities in patients with COPD. Chest 2005;
128:2025e34.
22. Mereles D, Ehlken N, Kreuscher S, et al. Exercise and respira-
tory training improve exercise capacity and quality of life in
patients with severe chronic pulmonary hypertension. Circu-
lation 2006;114:1482e9.
